Article Details

Akero picks up $65M to advance Amgen-licensed NASH drug

Retrieved on: 2018-06-24 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Akero picks up $65M to advance Amgen-licensed NASH drug. View article details on hiswai:

Excerpt

<div>The financing was led by Apple Tree Partners, <b>Atlas Venture</b>, venBio Partners, and Versant Ventures. To say NASH is a hot field would be an ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up